Los Angeles, CA, United States of America

Bassil I Dahiyat

This inventor holds 38 USPTO granted patents and 20 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Protein Engineering. Top assignees: Xencor, Inc., California Institute of Technology, Chugai Seiyaku Kabushiki Kaisha. Active years: 2001-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bassil I Dahiyat. Retrieved from https://idiyas.com/inventor/bassil-i-dahiyat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 38 (Patent Applications = 20)

% Patents Active = 86.8

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 10 (Patent Applications = 9)

Average Co-Inventor Count = 3.7

ph-index = 23

Forward Citations = 1,842(Granted Patents)

Location History:

Los Angeles, CA (US) (2001 - 2008)
Altadena, CA (US) (2007 - 2024)

Company Filing History:

California Institute of Technology

patents

2 out of 991

Chugai Seiyaku Kabushiki Kaisha

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

Areas of Expertise:

Antibody Variants

Fc Variants

Immunoglobulins

Protein Design

TNF-Alpha Proteins

Granulopoietic Activity

Automated Protein Design

Nucleic Acids

Xylanase

Growth Hormone Activity

Insulin-Like Activity

Modified Isoelectric Points

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492253 - ANTI-HUMAN C5 ANTIBODIES (2025-12-09),

2. 11932685 - Fc variants with altered binding to FcRn (2024-03-19),

3. 10336818 - Fc variants with altered binding to FcRn (2019-07-02),

4. 10118959 - Anti-glypican-3 antibody (2018-11-06),

5. 9605061 - Antibodies with modified isoelectric points (2017-03-28),

6. 9102739 - Anti-glypican-3 antibody (2015-08-11),

7. 8883973 - Fc variants with altered binding to FcRn (2014-11-11),

8. 8883147 - Immunoglobulins insertions, deletions, and substitutions (2014-11-11),

9. 8852586 - Fc variants with altered binding to FcRn (2014-10-07),

10. 8802820 - Fc variants with altered binding to FcRn (2014-08-12),

11. 8637641 - Antibodies with modified isoelectric points (2014-01-28),

12. 8399618 - Immunoglobulin insertions, deletions, and substitutions (2013-03-19),

13. 8394925 - Fc variants with altered binding to FcRn (2013-03-12),

14. 8367805 - Fc variants with altered binding to FcRn (2013-02-05),

15. 8338574 - FC variants with altered binding to FCRN (2012-12-25),

Title: The Innovative Journey of Bassil I Dahiyat

Introduction: Bassil I Dahiyat is a renowned inventor based in Los Angeles, CA, known for his groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Dahiyat holds several patents in the areas of protein engineering, drug discovery, and molecular biology, showcasing his continuous commitment to innovation.

Career Highlights: With a background in biochemistry and a Ph.D. in Chemistry from Stanford University, Dahiyat has had a successful career working in various biotech companies, where he has led teams in developing novel therapies and technologies.

Collaborations: Throughout his career, Dahiyat has collaborated with leading researchers and scientists in the industry, fostering a culture of creativity and excellence in his projects.

Conclusion: Bassil I Dahiyat's relentless pursuit of innovation and his passion for pushing the boundaries of science make him a true pioneer in the field of biotechnology, with a lasting impact on the industry.

Profile summary based on public USPTO records.